KY

KYNTRA BIO INC

KYNB·31572Q881·US·Common Stock·Healthcare - Biotechnology-13D/G

KYNB (KYNTRA BIO INC) is held by 21 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.1M), BlackRock, Inc. ($571,765), TWO SIGMA INVESTMENTS, LP ($335,685). Net institutional sentiment: Mixed.

21
Holders
Avg rating(3 Elite)
$3.4M
Total Value
39% (27)
Fund Consensus
9 buying - 14 selling
KYSmart Money Verdict
View all
Held by 21 funds
3 elite
Who's Trading
ActivistARArmistice Capital, LLC9.9%May 15, 2026
InsiderWTWettig ThaneBuy $20KMay 14, 2026
ActivistThe Vanguard GroupThe Vanguard Group4.4%Jul 29, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
156,607$1.1M0.0%+11.26%
38
Decreased
84,331(-0.4%)$571,7650.0%-42.78%
0
Decreased
49,511(-19.1%)$335,6850.0%-83.99%
0
Increased
45,998(+5.3%)$311,9350.0%-98.82%
17
Decreased
39,744(-0.0%)$269,4640.0%-91.69%
0
Increased
27,591(+192.5%)$187,0670.0%-16.50%
25
Decreased
27,481(-13.3%)$186,3210.0%-35.34%
0
New
23,942$162,3270.0%+11.26%
34
Unchanged
20,284$137,5260.0%-66.87%
0
Decreased
12,228(-2.1%)$82,9060.0%-12.53%
0
Decreased
4,492(-2.1%)$30,4560.0%-31.60%
0
New
1,424$9,6550.0%+11.26%
26
Decreased
488(-91.8%)$3,3080.0%-23.46%
0
New
193$1,3050.0%+11.26%
17
Increased
180(+76.5%)$1,2200.0%-77.17%
12
Decreased
137(-0.7%)$1,0000.0%-12.02%
0
Increased
50(+2.0%)$3390.0%-93.28%
8
Unchanged
12$780.0%-26.66%
0
New
1$70.0%+11.26%
17
Unchanged
1$70.0%+45.79%
0

Showing 1-20 of 27

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used